Medicaid Covers GLP-1 Obesity Meds in Just 13 States

Published on November 5, 2024

Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Under…

Read Full Article (External Site)